A recent study found that 7% of Canadian patients diagnosed with pancreatic cancer carry mutations in the BRCA1 and BRCA2 genes, with a higher prevalence observed in patients diagnosed at younger ages [12]. The gene discussed is BRCA2; the disease is pancreatic neoplasm.